References
- Bulger E. M., Maier R. V. Lipid mediators in the pathophysiology of critical illness. Crit. Care Med. 2000; 28(4)N27–N36, Suppl.[PUBMED], [INFOTRIEVE], [CSA]
- Uhl W., Beger H. G., Hoffmann G., Hanisch E., Schild A., Waydhas Ch., Entholzner E., Müller K., Kellermann W., Vogeser M., Leskopf W., Zügel M., Busch E. W., Büchler M. W. A multicenter study of phospholipase A2 in patients in intensive care unit. J. Am. Coll. Surg. 1995; 180(3)323–331, [PUBMED], [INFOTRIEVE], [CSA]
- Vadas P., Pruzanski W., Stefanski E., Sternby B., Mustard R., Bohnen J., Fraser I., Farewell V., Bombardier C. Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse. Crit. Care Med. 1988; 16(4)1–7, [PUBMED], [INFOTRIEVE]
- Schetz M., Ferdinande P., Van den Berghe G., Verwaest C., Lauwers P. Removal of pro‐inflammatory cytokines with renal replacement therapy: sense or nonsense?. Intensive Care Med. 1995; 21(2)169–176, [PUBMED], [INFOTRIEVE], [CSA]
- De Vriese A. S., Colardyn F. A., Philippe J. J., Vanholder R. C., DeSutter J. H., Lameire N. H. Cytokine removal during continuous hemofiltration in septic patients. J. Am. Soc. Nephrol. 1999; 10(4)846–853, [PUBMED], [INFOTRIEVE], [CSA]
- Kline J. A., Gordon B. E., Williams C., Blumenthal S., Watts J. A., Diaz‐Buxo J. Large‐pore hemodialysis in acute endotoxin shock. Crit. Care Med. 1999; 27(3)588–596, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 1992; 20(6)864–874
- Thadhani R., Pascual M., Bonventre J. V. Acute renal failure. N. Engl. J. Med. 1996; 334(22)1448–1460, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985; 13(10)818–829, [PUBMED], [INFOTRIEVE]
- Nakamura H., Kim D. K., Philbin D. M., Peterson M. B., Debros F., Koski G., Bonventre J. V. Heparin‐enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery. J. Clin. Invest. 1995; 95(3)1062–1070, [PUBMED], [INFOTRIEVE], [CSA]
- Murakami M., Shimbara S., Kambe T., Kuwata H., Winstead M. V., Tischfield J. A., Kudo I. The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. J. Biol. Chem. 1998; 273(23)14411–14423, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Song C. H., Choi J. S., Kim D. K., Kim J. C. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest. Ophthalmol. Vis. Sci. 1999; 40(11)2744–2748, [PUBMED], [INFOTRIEVE], [CSA]
- Murakami M., Kudo I., Inoue K. In vivo release and clearance of rat platelet phospholipase A2. Biochim. Biophys. Acta 1989; 1005(3)270–276, [PUBMED], [INFOTRIEVE]
- Yekebas E. F., Treede H., Knoefel W. T., Bloechle C., Fink E., Izbicki J. R. Influence of zero‐balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann. Surg. 1999; 229(4)514–522, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Katayama H. Comparison of continuous renal replacement therapy by clearance measurement. Journal of the Japanese Society of Intensive Care Medicine 1998; 5(2)115–121